|
|
|
| home > white papers > Protein Therapeutics - Reading Scientific Services Ltd (RSSL) |
|
|
 WHITE PAPERS |
|
Reading Scientific Services Ltd (RSSL)
|
|
Protein Therapeutics
|
|
The use of protein-based biological materials to treat patients suffering from a wide range of diseases is one of the success stories of modern medicine. The diseases treated include diabetes (insulin), growth hormone deficiencies (recombinant human growth hormone), inborn errors of metabolism (glucosylceramidase, alpha-galactosidase), and red blood cell deficiency (erythropoietin). As the market develops, the number of biopharmaceutical products both being submitted for regulatory approval and reaching the end of their patent life is increasing.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
rfxcel Covers the Cost of EMVO Onboarding Fees
May 23, 2018 - San Ramon, CA – rfxcel Corporation, a technically certified Gateway Provider for the European Medicines Verification Organisation (EMVO) announced today that it will pay the cost of statutory fees payable to EMVO* for all manufacturers (Marketing Authorisation Holders, MAHs) which select rfxcel as their Gateway Provider before June 15th 2018.
More info >> |
|
 |
White Papers |
 |
|
Blockbuster Drugs Need Blockbuster Components
West Pharmaceutical Services, Inc.
Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >> |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Medical Device USA 2018
11-12 July 2018, Minneapolis, Minnesota
6th Outsourcing in Clinical
Trials conference is the only clinical outsourcing platform for medical device
companies within Medical Alley this year.
More info >> |
|
|
|
